Elsa Wagner

🎯 Scientific Leader | Expert in Analytical Sciences & Biopharmaceutical Development With over 20 years of industrial experience in research and early-stage pharmaceutical development, I bring a strong track record of innovation and leadership in the characterization of complex biomolecules. 🔬 Specialized in developing advanced analytical methods for the structural characterization of therapeutic monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and recombinant proteins. I also conduct in silico developability assessments and stability studies to support biopharmaceutical development strategies. 💡 Recognized expert in Mass Spectrometry (HPLC-MS, UPLC-MS) and a broad range of separation techniques, including IEX, IEF, SEC, and SDS-PAGE. 👥 Experienced in team management and multi-project coordination in dynamic, cross-functional environments. 📣 Regularly invited as a speaker and chairwoman at international scientific conferences, and author/co-author of 30 publications in peer-reviewed journals. Passionate about turning scientific complexity into actionable insights to advance therapeutic innovation.